Zaremba Rabourn Amy
Insider CIK 1832343 · OCUP VP of Finance
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IRD Opus Genetics, Inc. | S Sale | 2026-04-23 | 2026-04-27 | 1,641 | $5.20 | $8.5K | 188,671 | SEC↗ |
| IRD Opus Genetics, Inc. | S Sale | 2026-03-16 | 2026-03-18 | 2,816 | $5.25 | $14.8K | 190,312 | SEC↗ |
| IRD Opus Genetics, Inc. | A Award | 2026-01-22 | 2026-01-26 | 86,500 | — | $0 | 193,128 | SEC↗ |
| IRD Opus Genetics, Inc. | F Tax w/h | 2026-01-18 | 2026-01-21 | 3,390 | $2.10 | $7.1K | 106,628 | SEC↗ |
| IRD Opus Genetics, Inc. | F Tax w/h | 2026-01-10 | 2026-01-13 | 3,950 | $1.93 | $7.6K | 110,018 | SEC↗ |
| IRD Opus Genetics, Inc. | A Award deriv | 2025-03-13 | 2025-03-17 | 39,500 | — | $0 | 39,500 | SEC↗ |
| IRD Opus Genetics, Inc. | A Award | 2025-03-13 | 2025-03-17 | 39,500 | — | $0 | 113,968 | SEC↗ |
| IRD Opus Genetics, Inc. | F Tax w/h | 2025-02-04 | 2025-02-06 | 8,190 | $1.14 | $9.3K | 74,468 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award deriv | 2024-01-18 | 2024-01-22 | 60,000 | — | $0 | 60,000 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award | 2024-01-18 | 2024-01-22 | 40,000 | — | $0 | 82,658 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | F Tax w/h | 2024-01-10 | 2024-01-12 | 3,950 | $3.27 | $12.9K | 42,658 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award deriv | 2023-01-10 | 2023-01-12 | 69,912 | — | $0 | 69,912 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award | 2023-01-10 | 2023-01-12 | 46,608 | — | $0 | 46,608 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award deriv | 2022-01-28 | 2022-02-01 | 50,000 | — | $0 | 50,000 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award deriv | 2020-11-11 | 2020-11-16 | 75,000 | — | $0 | 75,000 | SEC↗ |